Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 1;103(7):2468-2477.
doi: 10.1210/jc.2017-02629.

Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study

Affiliations

Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study

Jihye Park et al. J Clin Endocrinol Metab. .

Abstract

Context: Thyroid cancer survivors are at high risk of developing multiple cardiac and vascular conditions as consequence of cancer diagnosis and treatment. However, it is still unclear how the baseline and prognostic factors, as well as cancer treatments, play a role in increasing cardiac and vascular disease risk among thyroid cancer survivors.

Objective: To investigate the association between potential risk factors, treatment effects, and cardiovascular disease (CVD) outcomes in thyroid cancer survivors.

Design, setting, patients: Primary thyroid cancer survivors, diagnosed from 1997 to 2012 (n = 3822), were identified using the statewide Utah Population Database. The medical records were used to ascertain information on risk factors and CVD outcomes. Cox proportional hazards models were used to assess the risk of CVD with baseline demographic data and clinical factors.

Results: Among thyroid cancer survivors, age and year at cancer diagnosis, cancer stage, sex, baseline body mass index, baseline comorbidities, and TSH suppression therapy were significantly associated with CVD risk 1 to 5 years after cancer diagnosis. Patients who were male, overweight or obese, older at cancer diagnosis, and diagnosed with cancer since 2005 had an increased risk of CVD compared with patients who were female, had a normal body mass index, were younger at cancer diagnosis, and diagnosed with cancer from 1997 to 1999. Administration of TSH suppression therapy, distant metastases at cancer diagnosis, and a higher Charlson comorbidity index score were associated with an increased CVD risk among thyroid cancer survivors.

Conclusions: Our findings suggest that examining the effect of thyroid cancer diagnosis, cancer treatment, and demographic characteristics on the risk of CVD is critical.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Potential risk factors for CVD among thyroid cancer survivors, 1 to 5 y after cancer diagnosis. *For the models that violated proportional hazards assumptions, we used Cox models with cubic splines. aAdjusted for age at diagnosis, BMI at baseline, and CCI score. bAdjusted for diagnosis year, race, sex, BMI at baseline, and CCI score. cAdjusted for diagnosis year, age at diagnosis, race, sex, and CCI score. dAdjusted for diagnosis year, age at diagnosis, race, sex, BMI at baseline, and CCI score. eAdjusted for diagnosis year, age at diagnosis, race, sex, BMI at baseline, cancer stage at diagnosis, and CCI score. fAdjusted for diagnosis year, age at diagnosis, race, sex, and BMI at baseline.

Similar articles

Cited by

References

    1. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) program: Cancer Stat Facts: Thyroid Cancer. Available at: seer.cancer.gov/statfacts/html/thyro.html. Accessed 18 January 2017.
    1. National Cancer Institute. State Cancer Profiles. Available at: statecancerprofiles.cancer.gov/. Accessed 28 June 2017.
    1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–2921. - PubMed
    1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. - PubMed
    1. NCCN Clinical Practice Guidelines in Oncology. Thyroid Carcinoma. 2017. Available at: www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed 29 November 2017.

Publication types

MeSH terms